Australian Clinical Labs Ltd ( (AU:ACL) ) has issued an announcement.
Australian Clinical Labs Ltd has announced a change in its substantial holding status. The company has ceased to be a substantial holder as of March 6, 2025, impacting its voting securities and associations with other entities. This change could influence the company’s market position and stakeholder relationships.
More about Australian Clinical Labs Ltd
YTD Price Performance: -10.17%
Average Trading Volume: 652,576
Technical Sentiment Consensus Rating: Hold
Current Market Cap: A$619.8M
For an in-depth examination of ACL stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com